tiprankstipranks
Trending News
More News >
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (DE:6NQ)
:6NQ

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Revenue

Compare
0 Followers

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Revenue

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had a revenue of 13.41M in the quarter ending Sep 30, 2024, with -11.77%. This bring the company's revenue in the last twelve months to 62.66M, Decreased 9.25%. In the fiscal year ending Dec 31, 2023, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. had annual revenue of 58.61M with 16.32% growth.
Revenue (ttm)
62.66M
Revenue Growth
P/S Ratio
1.33
Revenue/Employee
€250,457
Employees
234
Market Cap
€77.66M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202358.61M8.22M+16.32%
Dec 31, 202250.38M9.23M+22.43%
Dec 31, 202141.15M995.00K+2.48%
Dec 31, 202040.16M1.05M+2.69%
Dec 31, 201939.11M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis